Fifty percent of the radiographic ineligibility was due to complete loss of medial tibio-femoral joint space. A further 13% withdrew from participation during the 'run-in' period. The baseline demographics of the LEGS study cohort (Table1) demonstrate the required screening pain of ≥4 out of 10 was not maintained at the subsequent baseline assessment (WOMAC) or 7-day Participant Diary by many participant. Conclusions: A comprehensive telephone screening reduced the burden of radiographic screenings. The two week 'run-in' of study procedures further reduced the number of participants likely to drop out soon after randomisation. It is difficult to identify people with knee osteoarthritis that have at least moderate ongoing pain, yet retain medial tibio-femoral joint space width >2mm. Purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) are the "Gold Standards" in the treatments of various pain and inflammation related disorders like arthritis. However, their oral administration and use of newer selective COX-2 NSAIDs known to induce severe intolerance in patients. Thus, the present work aims to compare the efficacy and safety of a epicutaneously applied diclofenac in novel liposomal gel vis-à-vis marketed gel and placebo for relief of signs and symptoms in osteoarthritis (OA) of knee. Methods: This was a randomized, double-blind, controlled trial on 36 patients with knee osteoarthritis. They were randomly assigned to liposomal gel, marketed gel and placebo, twice a day for 6 weeks. The patients were assessed by primary efficacy outcome measures included the changes from baseline to end of study on the WOMAC (Western Ontario McMaster Universities) Osteoarthritis Index. The radiographic imaging of OA in the knee was also performed for Kellgren-Lawrence criteria. Safety of the gel was also assessed by evaluating adverse events, vital signs, and irritation at the application site. Results: In liposomal gel treated group, the pain, stiffness and difficulty performing routine activities showed statistically significantly improvements on 6 weeks of treatment compared to the other tested gels. While, all the treatments were found to be well tolerated with no observed adverse event. Conclusions: Diclofenac in liposomal gel is superior to other tested formulations viz. marketed gel and placebo in the relieving the symptoms of OA of the knee. Hence, it can be concluded that diclofenac in liposomal gel can be a rational alternative to oral diclofenac formulations for management of various pain and inflammation related ailments including osteoarthritis.
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Purpose: The literature suggests ACL injuries and meniscal lesions are associated with the development of knee osteoarthritis (OA). There is limited evidence that surgical repair of these lesions diminishes future development of knee OA. A review of the long-term consequences of these injuries suggests that some 50% of those undergoing meniscectomy will develop OA between10 to 20 years after the surgery. Estimates from the literature indicate that 10% to 90% of individuals with ACL injury develop OA within 10 to 20 years of the lesion. This raises the question as to what proportion of all knee OA cases might be associated with previous arthroscopic surgery. Methods: A study to estimate the proportion of individuals who will develop OA after having arthroscopic surgery was designed by juxtaposing data form different sources. (a) Data on the age-and sex-specific rates of arthroscopic surgery (closed repair of the knee which includes menisectomy and ACL repairs) in Ontario, Canada for the population aged 5-45 years, (b) data on the age and sex incidence of OA estimated from physician billing data in British Columbia, Canada, (c) Population data for Canada, and d) estimates of the proportion of individuals with arthroscopic surgery who develop OA were combined to calculate estimates of the number of incident OA cases likely due to arthroscopic surgery at the end of a 10 year period. The rates of arthroscopic surgery were applied to the population to estimate the number of individuals with this type of surgery. OA incidence rates were also applied to the population to estimate the number of new OA cases every year. The following scenarios for the proportion developing OA over a period of 10 years were used: 10%, 20%, 30% and 40%. The main assumptions made were: constant arthroscopic rates and incidence rates of
